Pre-Conference Workshop Day

GO TO DAY ONE

Monday 9, June 2025

9:30 - 12:00 Workshop A

Optimizing Evidence Generation in Early Clinical Stages to Enhance the Value Proposition for Market Access & Reimbursement

The value of optimizing evidence generation in early stages comes with its fair share of problems such as a lack of shared clinical trial infrastructure, resource allocation issues, and lack of effective cross-functional collaboration. How can we overcome these challenges?

This workshop will cover:

  • Discover how incorporating real-world evidence early can strengthen clinical trial
    design and endpoint selection
  • Explore strategies to align early evidence generation with payer and regulatorexpectations to support market access and reimbursement discussions
  • Learn best practices for leveraging early-stage data to build robust value propositions and accelerate time-to-market

Workshop Leaders

Lene Hammer-Helmich 2nd IMPACCT Real World Evidence Europe Summit

Lene Hammer Helmich
Director, Head of RWE & Epidemiology
Lundbeck

Joan Mendivil Pharvaris

Joan Mendivil
Head Evidence & Outcomes
Pharvaris

 

12:00 pm Lunch

13:00 - 16:00pm Workshop B

Maximizing Synergies Between Industry & Public Research to Elevate RWE Utility

The importance of industry and public research collaboration is being increasingly
recognized. What are the current barriers in fostering collaboration between industry
and public research institutions? How can we identify best practices for data sharing?
How can we co-develop methodologies to leverage collective expertise to drive
innovation and informed decision making?

This workshop will cover:

  • Explore strategies to strengthen collaboration between industry and public research entities to enhance the quality and scope of real-world evidence (RWE)
  • Learn how to optimize data sharing, infrastructure, and expertise to maximize theutility and impact of RWE across both sectors
  • Discover methods for aligning industry goals with public research priorities to ensure that RWE supports both commercial needs and societal health outcomes

Workshop Leaders

Onyinye Diribe 2nd IMPACCT Real World Evidence Summit Europe

Onyinye Diribe
HEOR Real World Evidence Lead
Sanofi

Marcus Lawrance 2nd IMPACCT Real World Evidence Europe Summit

Marcus Lawrance
Director - Global Oncology & Data Strategy
AstraZeneca

FULL EVENT GUIDE
DAY ONE